Bank Pictet & Cie Asia Ltd. lowered its stake in shares of Aetna (NYSE:AET) by 41.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,499 shares of the company’s stock after selling 1,794 shares during the period. Bank Pictet & Cie Asia Ltd.’s holdings in Aetna were worth $422,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Focused Wealth Management Inc raised its stake in Aetna by 84.5% during the fourth quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock worth $118,000 after purchasing an additional 300 shares during the period. Cerebellum GP LLC purchased a new position in Aetna during the fourth quarter worth approximately $125,000. Centaurus Financial Inc. purchased a new position in Aetna during the first quarter worth approximately $128,000. James Hambro & Partners purchased a new position in Aetna during the fourth quarter worth approximately $158,000. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in Aetna during the fourth quarter worth approximately $180,000. 87.01% of the stock is currently owned by institutional investors.
A number of research firms have weighed in on AET. Credit Suisse Group increased their price target on shares of Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 31st. Citigroup downgraded shares of Aetna from a “buy” rating to a “neutral” rating and increased their price target for the stock from $187.89 to $212.00 in a research note on Wednesday, January 31st. Cowen reaffirmed a “buy” rating and set a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. Piper Jaffray reaffirmed a “buy” rating and set a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. Finally, Deutsche Bank raised shares of Aetna from a “hold” rating to a “buy” rating and increased their price target for the stock from $195.00 to $212.00 in a research note on Monday, January 22nd. Eight investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $196.36.
Aetna opened at $176.81 on Friday, Marketbeat.com reports. Aetna has a 52-week low of $139.45 and a 52-week high of $194.40. The firm has a market capitalization of $57.91 billion, a PE ratio of 17.93, a price-to-earnings-growth ratio of 1.49 and a beta of 0.64. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.47.
Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, May 1st. The company reported $3.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.97 by $0.22. Aetna had a net margin of 5.76% and a return on equity of 21.42%. The company had revenue of $15.34 billion during the quarter, compared to analyst estimates of $15.32 billion. During the same quarter in the prior year, the business earned $2.71 earnings per share. The business’s quarterly revenue was up 1.1% compared to the same quarter last year. research analysts anticipate that Aetna will post 11.06 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. Aetna’s payout ratio is currently 20.28%.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.